About
Q32 Bio Inc (NASDAQ:QTTB) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 10 2026
Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Feb 18 2026
Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 17 2026
Q32 Bio Announces $10.5 Million Registered Direct Offering
Dec 1 2025
Q32 Bio Sells Complement Inhibitor ADX-097
Financials
Revenue
$53.74 M
Market Cap
$71.98 M
P/E Ratio
2.03
EPS
2.42
Translate